Cut Down Influenza A with Sequivity(R) IAV-S NA

Veterinary Service Issues Revised Guidelines for Autogenous Biologics

The Center for Veterinary Biologics (CVB) recently added a revised version of Veterinary Services (VS) Memorandum 800.69 (Guidelines for Autogenous Biologics) to its website which may be accessed by clicking through the following link: CVB Newly Published Information. [Source: USDA APHIS Bulletin, November 9, 2016]

VS Memorandum 800.69 was signed on September 28, 2016 and cancels the previous version from August 30, 2002.

The purpose of this memorandum describes the present procedures and guidelines for interpretation of the requirements for autogenous biologics under the provisions of title 9, Code of Federal Regulations (9 CFR), section 113.113, 113.3(b)(8), and the administrative terminology in section 101.2; to inform licensees that autogenous isolates may be used for 24 months without requesting permission from the Center for Veterinary Biologics (CVB); and, to notify licensees that shipments to adjacent and nonadjacent herds will be permitted, provided the information cited in 9 CFR 113.113(a)(2) and (3) is on file with the licensee prior to the shipment of an autogenous product for use in a herd other than the herd of origin.